Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Serotonin 1a (5-HT1a) receptor | Starlite/ChEMBL | No references |
Homo sapiens | adrenoceptor beta 3 | Starlite/ChEMBL | No references |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | Starlite/ChEMBL | No references |
Rattus norvegicus | Peripheral myelin protein 22 | Starlite/ChEMBL | No references |
Homo sapiens | adrenoceptor beta 1 | Starlite/ChEMBL | No references |
Homo sapiens | adrenoceptor beta 2, surface | Starlite/ChEMBL | No references |
Homo sapiens | cytochrome P450, family 2, subfamily D, polypeptide 6 | Starlite/ChEMBL | No references |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0155 | 0.1734 | 0.4779 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.001 | 0.0015 | 0.0015 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0019 | 0.0119 | 0.0119 |
Schistosoma mansoni | peroxidasin | 0.0155 | 0.1734 | 0.5079 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0036 | 0.032 | 1 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | RE15519p | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0119 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0036 | 0.032 | 0.0889 |
Echinococcus granulosus | protein cereblon | 0.0297 | 0.3414 | 0.3414 |
Echinococcus multilocularis | protein cereblon | 0.0297 | 0.3414 | 0.3492 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0119 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.001 | 0.0015 | 0.0045 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | adenoreceptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0015 | 0.0015 |
Schistosoma mansoni | histamine h1 receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | dro:myosuppressin receptor | 0.0019 | 0.0119 | 0.0122 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.001 | 0.0015 | 0.0015 |
Onchocerca volvulus | Peroxidasin homolog | 0.0155 | 0.1734 | 0.5057 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | transcription factor Dp 1 | 0.0038 | 0.0346 | 0.0346 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Echinococcus granulosus | g protein coupled receptor | 0.0019 | 0.0119 | 0.0119 |
Schistosoma mansoni | thyroid hormone receptor | 0.0135 | 0.1497 | 0.4383 |
Echinococcus multilocularis | g protein coupled receptor | 0.0019 | 0.0119 | 0.0122 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0324 | 0.5073 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.1863 | 0.5133 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0022 | 0.0153 | 0.1913 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0166 | 0.1863 | 0.1863 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0125 | 0.1378 | 0.1409 |
Brugia malayi | Peroxidasin | 0.0155 | 0.1734 | 0.5079 |
Loa Loa (eye worm) | neuropeptide F receptor | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.0036 | 0.0324 | 0.0331 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.001 | 0.0015 | 0.0045 |
Echinococcus granulosus | tachykinin peptides receptor 99D | 0.0019 | 0.0119 | 0.0119 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.001 | 0.0015 | 0.0016 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.001 | 0.0015 | 0.0045 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0228 | 0.2603 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.001 | 0.0015 | 0.0042 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0022 | 0.0153 | 0.2404 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Mycobacterium tuberculosis | Conserved protein | 0.0036 | 0.032 | 0.068 |
Echinococcus granulosus | dro:myosuppressin receptor | 0.0019 | 0.0119 | 0.0119 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0015 | 0.0016 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0063 | 0.0638 | 0.0638 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0036 | 0.032 | 0.068 |
Brugia malayi | Dopamine receptor protein 1, putative (partial) | 0.0019 | 0.0119 | 0.0349 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0155 | 0.1734 | 0.4779 |
Brugia malayi | G-protein-linked acetylcholine receptor protein 2, putative | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.001 | 0.0015 | 0.0045 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.0019 | 0.0119 | 0.0349 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0324 | 0.4504 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Schistosoma mansoni | biogenic amine receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | Animal haem peroxidase family protein | 0.0155 | 0.1734 | 0.5079 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0066 | 0.0673 | 0.0673 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0036 | 0.032 | 0.0937 |
Toxoplasma gondii | thioredoxin reductase | 0.0063 | 0.0638 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Plasmodium vivax | hypothetical protein, conserved | 0.0036 | 0.032 | 0.4438 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Schistosoma mansoni | biogenic amine receptor | 0.0019 | 0.0119 | 0.0349 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0066 | 0.0673 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.2876 | 0.8424 |
Schistosoma mansoni | biogenic amine (dopamine) receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0119 | 0.0122 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0066 | 0.0673 | 0.1971 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0166 | 0.1863 | 0.5456 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0066 | 0.0673 | 0.1971 |
Echinococcus multilocularis | alpha 1A adrenergic receptor | 0.0019 | 0.0119 | 0.0122 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0036 | 0.032 | 1 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Onchocerca volvulus | 0.0036 | 0.0324 | 0.0908 | |
Echinococcus multilocularis | neuropeptides capa receptor | 0.0019 | 0.0119 | 0.0122 |
Toxoplasma gondii | ABC1 family protein | 0.0036 | 0.032 | 0.5014 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0066 | 0.0673 | 0.1855 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0022 | 0.0153 | 0.1913 |
Plasmodium falciparum | glutathione reductase | 0.0022 | 0.0153 | 0.2404 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0036 | 0.032 | 0.068 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Plasmodium falciparum | thioredoxin reductase | 0.0022 | 0.0153 | 0.2404 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Echinococcus multilocularis | neuropeptide receptor | 0.0019 | 0.0119 | 0.0122 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.001 | 0.0015 | 0.0045 |
Loa Loa (eye worm) | beta-lactamase | 0.0036 | 0.032 | 0.0882 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.2876 | 0.7926 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.001 | 0.0015 | 0.0016 |
Brugia malayi | Unidentified vitellogenin-linked transcript protein 6, putative | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Schistosoma mansoni | opsin-like receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0019 | 0.0119 | 0.0122 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0015 | 0.0015 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.001 | 0.0015 | 0.0045 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0066 | 0.0673 | 1 |
Brugia malayi | hypothetical protein | 0.0297 | 0.3414 | 1 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Schistosoma mansoni | neuropeptide F-like receptor | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.001 | 0.0015 | 0.0042 |
Mycobacterium leprae | conserved hypothetical protein | 0.0036 | 0.032 | 1 |
Brugia malayi | Serotonin receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.001 | 0.0015 | 0.0045 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Brugia malayi | gonadotropin-releasing hormone receptor 2 | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0119 |
Echinococcus granulosus | alpha 1A adrenergic receptor | 0.0019 | 0.0119 | 0.0119 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0022 | 0.0153 | 0.1913 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0036 | 0.032 | 0.068 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0036 | 0.032 | 0.032 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Echinococcus multilocularis | serotonin receptor | 0.0166 | 0.1863 | 0.1905 |
Brugia malayi | Dopamine receptor protein 2 | 0.0019 | 0.0119 | 0.0349 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0036 | 0.032 | 0.068 |
Brugia malayi | larval opioid receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | g-protein coupled receptor | 0.0019 | 0.0119 | 0.0122 |
Echinococcus multilocularis | biogenic amine (5HT) receptor | 0.0019 | 0.0119 | 0.0122 |
Brugia malayi | Dopamine receptor protein 1 | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | conserved hypothetical protein | 0.0833 | 0.9777 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0066 | 0.0673 | 1 |
Brugia malayi | ecdysteroid receptor | 0.001 | 0.0015 | 0.0045 |
Treponema pallidum | NADH oxidase | 0.0022 | 0.0153 | 0.5 |
Echinococcus granulosus | g protein coupled receptor | 0.0019 | 0.0119 | 0.0119 |
Brugia malayi | Serotonin/octopamine receptor family protein 7 | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0297 | 0.3414 | 1 |
Echinococcus multilocularis | pyroglutamylated rfamide peptide receptor | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | Animal haem peroxidase family protein | 0.0155 | 0.1734 | 0.5079 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.001 | 0.0015 | 0.0045 |
Echinococcus granulosus | 7tm_1 domain containing protein | 0.0019 | 0.0119 | 0.0119 |
Leishmania major | hypothetical protein, conserved | 0.0036 | 0.032 | 0.4505 |
Echinococcus multilocularis | neuropeptide FF receptor 2 | 0.0019 | 0.0119 | 0.0122 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.001 | 0.0015 | 0.0045 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0022 | 0.0153 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.0155 | 0.1734 | 0.5079 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0125 | 0.1378 | 0.1378 |
Echinococcus multilocularis | neuropeptide Y receptor | 0.0019 | 0.0119 | 0.0122 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0036 | 0.032 | 0.0889 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Echinococcus multilocularis | tachykinin peptides receptor 99D | 0.0019 | 0.0119 | 0.0122 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Loa Loa (eye worm) | melatonin receptor type 1A | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | coup transcription factor | 0.001 | 0.0015 | 0.0045 |
Mycobacterium ulcerans | beta-lactamase | 0.0036 | 0.032 | 1 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0022 | 0.0153 | 0.0449 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0015 | 0.0016 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0036 | 0.0324 | 0.0331 |
Echinococcus multilocularis | orexin receptor type 2 | 0.0019 | 0.0119 | 0.0122 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Loa Loa (eye worm) | unidentified vitellogenin-linked transcript protein 6 | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0022 | 0.0153 | 0.0449 |
Echinococcus multilocularis | FTZ F1 alpha | 0.001 | 0.0015 | 0.0016 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0019 | 0.0119 | 0.0122 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0036 | 0.032 | 0.0937 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Trichomonas vaginalis | esterase, putative | 0.0036 | 0.032 | 0.0889 |
Brugia malayi | putative neuropeptide receptor NPR1 | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | biogenic amine (octopamine/dopamine) receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0119 |
Plasmodium vivax | glutathione reductase, putative | 0.0063 | 0.0638 | 1 |
Echinococcus granulosus | geminin | 0.0168 | 0.189 | 0.189 |
Onchocerca volvulus | Protein cereblon homolog | 0.0297 | 0.3414 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0063 | 0.0638 | 1 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0066 | 0.0673 | 0.1899 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0022 | 0.0153 | 0.1913 |
Echinococcus granulosus | serotonin receptor | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0022 | 0.0153 | 0.1526 |
Brugia malayi | follicle stimulating hormone receptor | 0.0247 | 0.2826 | 0.8276 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Onchocerca volvulus | 0.0155 | 0.1734 | 0.5057 | |
Brugia malayi | putative neuropeptide receptor | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0315 | 0.3629 | 1 |
Brugia malayi | hypothetical protein | 0.0121 | 0.1329 | 0.3891 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0119 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.001 | 0.0015 | 0.0045 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0036 | 0.032 | 0.0882 |
Mycobacterium ulcerans | lipase LipD | 0.0036 | 0.032 | 1 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | neuropeptide F-like receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | g protein coupled receptor | 0.0019 | 0.0119 | 0.0122 |
Echinococcus multilocularis | thyrotropin releasing hormone receptor | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0324 | 0.0948 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.189 | 0.5536 |
Onchocerca volvulus | Dual oxidase homolog | 0.0155 | 0.1734 | 0.5057 |
Onchocerca volvulus | Dopamine\/Ecdysteroid receptor homolog | 0.0019 | 0.0119 | 0.0306 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.001 | 0.0015 | 0.0016 |
Echinococcus granulosus | G protein coupled receptor 139 | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0247 | 0.2826 | 0.7786 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | neuropeptide F receptor | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | G-protein coupled receptor | 0.0019 | 0.0119 | 0.0328 |
Echinococcus multilocularis | fmrfamide receptor | 0.0019 | 0.0119 | 0.0122 |
Brugia malayi | Serotonin receptor | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | peptide (FMRFamide/somatostatin)-like receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | steroid hormone receptor | 0.001 | 0.0015 | 0.0045 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.001 | 0.0015 | 0.0045 |
Echinococcus multilocularis | g protein coupled receptor | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | RecQ helicase | 0.0021 | 0.0147 | 0.0406 |
Brugia malayi | G-protein coupled receptor | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Brugia malayi | GnHR receptor homolog | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.001 | 0.0015 | 0.0045 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.032 | 0.0882 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0063 | 0.0638 | 0.1979 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0324 | 0.0324 |
Trypanosoma brucei | trypanothione reductase | 0.0063 | 0.0638 | 0.9457 |
Brugia malayi | Animal haem peroxidase family protein | 0.0155 | 0.1734 | 0.5079 |
Echinococcus granulosus | allatostatin A receptor | 0.0019 | 0.0119 | 0.0119 |
Schistosoma mansoni | growth hormone secretagogue receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | Animal haem peroxidase family protein | 0.0155 | 0.1734 | 0.5079 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.001 | 0.0015 | 0.0045 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | G-protein-linked acetylcholine receptor protein 2 | 0.0019 | 0.0119 | 0.0328 |
Mycobacterium tuberculosis | Conserved protein | 0.0036 | 0.032 | 0.068 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | gonadotropin-releasing hormone receptor 2 | 0.0019 | 0.0119 | 0.0328 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.3288 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0036 | 0.032 | 0.0889 |
Schistosoma mansoni | neuropeptide receptor | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | histamine-responsive GPCR (AAF21638) | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0019 | 0.0119 | 0.0122 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | peptide (allatostatin)-like receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | FTZ F1 alpha | 0.001 | 0.0015 | 0.0015 |
Loa Loa (eye worm) | 5-hydroxytryptamine 2C receptor | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0324 | 0.0948 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0022 | 0.0153 | 0.0153 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | neuropeptide receptor | 0.0019 | 0.0119 | 0.0122 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0155 | 0.1734 | 0.5057 |
Loa Loa (eye worm) | neuropeptide F receptor | 0.0019 | 0.0119 | 0.0328 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Echinococcus multilocularis | geminin | 0.0168 | 0.189 | 0.1933 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.001 | 0.0015 | 0.0045 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0324 | 0.0948 |
Echinococcus multilocularis | G-protein coupled receptor, putative | 0.0019 | 0.0119 | 0.0122 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0014 | 0.0064 | 0.1005 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Onchocerca volvulus | 0.0036 | 0.032 | 0.0896 | |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Onchocerca volvulus | Neuropeptide F receptor homolog | 0.0019 | 0.0119 | 0.0306 |
Loa Loa (eye worm) | hypothetical protein | 0.0166 | 0.1863 | 0.5133 |
Echinococcus granulosus | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.032 | 0.0882 |
Echinococcus granulosus | neuropeptide s receptor | 0.0019 | 0.0119 | 0.0119 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0066 | 0.0673 | 1 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.001 | 0.0015 | 0.0045 |
Brugia malayi | beta-lactamase family protein | 0.0036 | 0.032 | 0.0937 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Schistosoma mansoni | thyroid hormone receptor | 0.0135 | 0.1497 | 0.4383 |
Brugia malayi | G protein-coupled receptor F59B2.13 | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0119 | 0.0122 |
Echinococcus multilocularis | allatostatin A receptor | 0.0019 | 0.0119 | 0.0122 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0036 | 0.032 | 0.068 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | peroxidasin | 0.0155 | 0.1734 | 0.1774 |
Echinococcus granulosus | sex peptide receptor | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Mycobacterium tuberculosis | Conserved protein | 0.0036 | 0.032 | 0.068 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0324 | 0.0948 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0017 | 0.0095 | 0.0277 |
Schistosoma mansoni | opsin-like receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | neuropeptide receptor | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.001 | 0.0015 | 0.0042 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0063 | 0.0638 | 1 |
Echinococcus multilocularis | peptide (allatostatin:somatostatin) | 0.0019 | 0.0119 | 0.0122 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Echinococcus multilocularis | G protein coupled receptor 139 | 0.0019 | 0.0119 | 0.0122 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.001 | 0.0015 | 0.0045 |
Schistosoma mansoni | peptide (FMRFamide/somatostatin)-like receptor | 0.0019 | 0.0119 | 0.0349 |
Onchocerca volvulus | 0.0155 | 0.1734 | 0.5057 | |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0066 | 0.0673 | 0.0688 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0155 | 0.1734 | 0.4779 |
Onchocerca volvulus | Peroxidasin homolog | 0.0155 | 0.1734 | 0.5057 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.032 | 0.0882 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0036 | 0.032 | 0.4505 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Echinococcus multilocularis | transcription factor Dp 1 | 0.0038 | 0.0346 | 0.0354 |
Echinococcus multilocularis | neuropeptides capa receptor | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.032 | 0.0882 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus granulosus | orexin receptor type 2 | 0.0019 | 0.0119 | 0.0119 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0036 | 0.032 | 0.068 |
Schistosoma mansoni | amine GPCR | 0.0019 | 0.0119 | 0.0349 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0022 | 0.0153 | 0.1526 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Echinococcus granulosus | 7TM GPCR rhodopsin | 0.0019 | 0.0119 | 0.0119 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0022 | 0.0153 | 0.0377 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0016 | 0.0085 | 0.0249 |
Echinococcus granulosus | g-protein coupled receptor | 0.0019 | 0.0119 | 0.0119 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Schistosoma mansoni | muscarinic acetylcholine (GAR) receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | neuropeptide receptor | 0.0019 | 0.0119 | 0.0119 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0015 | 0.0015 |
Echinococcus granulosus | neuropeptide Y receptor | 0.0019 | 0.0119 | 0.0119 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.001 | 0.0015 | 0.0016 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0019 | 0.0119 | 0.0122 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | peptide allatostatin:somatostatin | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus multilocularis | somatostatin receptor | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Echinococcus granulosus | G protein coupled 5 hydroxytryptamine receptor | 0.0019 | 0.0119 | 0.0119 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.001 | 0.0015 | 0.0015 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0035 | 0.0308 | 0.0308 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0022 | 0.0153 | 0.2404 |
Schistosoma mansoni | thyrotropin-releasing hormone receptor | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0324 | 0.0948 |
Loa Loa (eye worm) | TYRA-2 protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | 0.0019 | 0.0119 | 0.0119 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0022 | 0.0153 | 0.1913 |
Schistosoma mansoni | opsin-like receptor | 0.0019 | 0.0119 | 0.0349 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0022 | 0.0153 | 0.5 |
Loa Loa (eye worm) | glutathione reductase | 0.0063 | 0.0638 | 0.1758 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0036 | 0.032 | 0.4505 |
Echinococcus granulosus | thyrotropin releasing hormone receptor | 0.0019 | 0.0119 | 0.0119 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | neuropeptide FF receptor 2 | 0.0019 | 0.0119 | 0.0119 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0036 | 0.032 | 0.0327 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0022 | 0.0153 | 0.2404 |
Brugia malayi | Blistered cuticle protein 3 | 0.0155 | 0.1734 | 0.5079 |
Brugia malayi | Dopamine receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | AKH receptor | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | alpha-1 adrenergic receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | Tachykinin-like peptides receptor 99D | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | somatostatin receptor | 0.0019 | 0.0119 | 0.0119 |
Schistosoma mansoni | hypothetical protein | 0.0062 | 0.0637 | 0.1865 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0036 | 0.032 | 0.0937 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.001 | 0.0015 | 0.0045 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0036 | 0.032 | 0.0889 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | beta-lactamase family protein | 0.0036 | 0.032 | 0.0937 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.001 | 0.0015 | 0.0045 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0021 | 0.0147 | 0.0359 |
Echinococcus granulosus | peroxidasin | 0.0155 | 0.1734 | 0.1734 |
Mycobacterium leprae | Probable lipase LipE | 0.0036 | 0.032 | 1 |
Echinococcus multilocularis | sex peptide receptor | 0.0019 | 0.0119 | 0.0122 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0022 | 0.0153 | 0.2404 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0324 | 0.0892 |
Brugia malayi | G protein-coupled receptor | 0.0019 | 0.0119 | 0.0349 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0036 | 0.032 | 0.0889 |
Echinococcus granulosus | neuropeptides capa receptor | 0.0019 | 0.0119 | 0.0119 |
Echinococcus multilocularis | neuropeptide Y receptor | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0155 | 0.1734 | 0.4779 |
Schistosoma mansoni | neuropeptide receptor | 0.0019 | 0.0119 | 0.0349 |
Plasmodium falciparum | thioredoxin reductase | 0.0063 | 0.0638 | 1 |
Echinococcus granulosus | neuropeptide Y receptor | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus multilocularis | growth hormone secretagogue receptor type 1 | 0.0019 | 0.0119 | 0.0122 |
Onchocerca volvulus | 0.0036 | 0.032 | 0.0896 | |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Loa Loa (eye worm) | steroid hormone receptor | 0.001 | 0.0015 | 0.0042 |
Schistosoma mansoni | rhodopsin-like orphan GPCR | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.001 | 0.0015 | 0.0045 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0022 | 0.0153 | 0.5 |
Schistosoma mansoni | neuropeptide f receptor 76f | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.032 | 0.0882 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.001 | 0.0015 | 0.0015 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0135 | 0.1497 | 0.1531 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0036 | 0.032 | 0.4505 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus multilocularis | G protein coupled 5 hydroxytryptamine receptor | 0.0019 | 0.0119 | 0.0122 |
Schistosoma mansoni | peptide (FMRFamide/neurokinin-3)-like receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0063 | 0.0638 | 0.0653 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0022 | 0.0153 | 0.1913 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.001 | 0.0015 | 0.0045 |
Echinococcus multilocularis | serotonin receptor | 0.0166 | 0.1863 | 0.1905 |
Brugia malayi | sulfakinin receptor protein | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.001 | 0.0015 | 0.0016 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Echinococcus granulosus | growth hormone secretagogue receptor type 1 | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.001 | 0.0015 | 0.0042 |
Onchocerca volvulus | 0.0019 | 0.0119 | 0.0306 | |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.001 | 0.0015 | 0.0045 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0022 | 0.0153 | 0.0377 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0022 | 0.0153 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.189 | 0.5536 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.001 | 0.0015 | 0.0042 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0097 | 0.0266 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | ORL1-like opioid receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0019 | 0.0119 | 0.0119 |
Echinococcus granulosus | bloom syndrome protein | 0.0021 | 0.0147 | 0.0147 |
Echinococcus granulosus | g protein linked acetylcholine receptor gar 2a | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.001 | 0.0015 | 0.0042 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0063 | 0.0638 | 0.9457 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0022 | 0.0153 | 0.0157 |
Brugia malayi | Melatonin receptor type 1A | 0.0019 | 0.0119 | 0.0349 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0019 | 0.0117 | 0.1832 |
Echinococcus multilocularis | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0122 |
Leishmania major | trypanothione reductase | 0.0063 | 0.0638 | 0.9457 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.0019 | 0.0119 | 0.0119 |
Schistosoma mansoni | neuropeptide receptor | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0297 | 0.3414 | 0.9408 |
Schistosoma mansoni | biogenic amine receptor | 0.0019 | 0.0119 | 0.0349 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0022 | 0.0153 | 0.1913 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Schistosoma mansoni | hypothetical protein | 0.0125 | 0.1378 | 0.4035 |
Loa Loa (eye worm) | G-protein coupled receptor | 0.0019 | 0.0119 | 0.0328 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.001 | 0.0015 | 0.0015 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0021 | 0.0147 | 0.0359 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Echinococcus granulosus | neuropeptides capa receptor | 0.0019 | 0.0119 | 0.0119 |
Onchocerca volvulus | 0.0036 | 0.032 | 0.0896 | |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Onchocerca volvulus | 0.0155 | 0.1734 | 0.5057 | |
Brugia malayi | G-protein coupled receptor | 0.0019 | 0.0119 | 0.0349 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0022 | 0.0153 | 0.1913 |
Schistosoma mansoni | peroxidasin | 0.0155 | 0.1734 | 0.5079 |
Onchocerca volvulus | Peroxidase homolog | 0.0155 | 0.1734 | 0.5057 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.032 | 0.0882 |
Mycobacterium ulcerans | hypothetical protein | 0.0036 | 0.032 | 1 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.001 | 0.0015 | 0.0045 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Brugia malayi | beta-lactamase | 0.0036 | 0.032 | 0.0937 |
Echinococcus multilocularis | 7TM GPCR, rhodopsin | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Echinococcus multilocularis | fmrfamide receptor | 0.0019 | 0.0119 | 0.0122 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Brugia malayi | hypothetical protein | 0.0155 | 0.1734 | 0.5079 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0155 | 0.1734 | 0.4779 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Onchocerca volvulus | Peroxidase homolog | 0.0155 | 0.1734 | 0.5057 |
Schistosoma mansoni | hypothetical protein | 0.0297 | 0.3414 | 1 |
Echinococcus multilocularis | bloom syndrome protein | 0.0021 | 0.0147 | 0.0151 |
Schistosoma mansoni | nuclear hormone receptor | 0.001 | 0.0015 | 0.0045 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.001 | 0.0015 | 0.0045 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0015 | 0.0042 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0063 | 0.0638 | 0.1758 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0119 |
Echinococcus granulosus | fmrfamide receptor | 0.0019 | 0.0119 | 0.0119 |
Brugia malayi | Thioredoxin reductase | 0.0063 | 0.0638 | 0.1869 |
Schistosoma mansoni | peptide (allatostatin/somatostatin)-like receptor | 0.0019 | 0.0119 | 0.0349 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0119 | 0.0328 |
Schistosoma mansoni | myosin xvIII | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0021 | 0.0147 | 0.0432 |
Brugia malayi | glutathione reductase | 0.0063 | 0.0638 | 0.1869 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.001 | 0.0015 | 0.0045 |
Brugia malayi | neuropeptide F receptor | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | nuclear receptor NHR-88 | 0.001 | 0.0015 | 0.0045 |
Schistosoma mansoni | ancient conserved domain protein 2 (cyclin m2) | 0.0019 | 0.0119 | 0.0349 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0016 | 0.0085 | 0.0249 |
Brugia malayi | nuclear hormone receptor | 0.001 | 0.0015 | 0.0045 |
Echinococcus granulosus | g protein coupled receptor | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.001 | 0.0015 | 0.0042 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0036 | 0.032 | 0.068 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.001 | 0.0015 | 0.0045 |
Onchocerca volvulus | 0.0286 | 0.3288 | 0.9628 | |
Schistosoma mansoni | neuropeptide receptor | 0.0019 | 0.0119 | 0.0349 |
Echinococcus granulosus | rhodopsin orphan GPCR | 0.0019 | 0.0119 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.1734 | 0.4779 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 7.8 | Beta-blocking activity of the compound was measured by applying the stepwise linear discriminate analysis; Active | ChEMBL. | No reference |
Activity (functional) | = 7.8 | Beta-blocking activity of the compound was measured by applying the stepwise linear discriminate analysis; Active | ChEMBL. | No reference |
EC50 (functional) | = 40 uM | Antitrypanosomal activity against Trypanosoma cruzi amastigotes infected in BESM cells measured after 88 hrs postinfection by HTS assay | ChEMBL. | 20547819 |
IC50 (binding) | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Chemokine CXCR1 (IL-8A) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC) | ChEMBL. | No reference | |
IC50 (binding) | DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC) | ChEMBL. | No reference | |
IC50 (binding) | = 0.02 uM | DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) | ChEMBL. | No reference |
IC50 (binding) | = 0.047 uM | DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) | ChEMBL. | No reference |
IC50 (binding) | = 0.267 uM | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) | ChEMBL. | No reference |
IC50 (binding) | = 0.458 uM | DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) | ChEMBL. | No reference |
IC50 (binding) | = 1.523 uM | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | ChEMBL. | No reference |
IC50 (binding) | = 1.581 uM | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | ChEMBL. | No reference |
IC50 (binding) | = 5.4764 uM | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference |
Ki (binding) | DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr)) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr)) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr)) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Chemokine CXCR1 (IL-8A) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein) | ChEMBL. | No reference | |
Ki (binding) | DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine) | ChEMBL. | No reference | |
Ki (binding) | = 0.014 uM | DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177) | ChEMBL. | No reference |
Ki (binding) | = 0.027 uM | DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol) | ChEMBL. | No reference |
Ki (binding) | = 0.153 uM | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) | ChEMBL. | No reference |
Ki (binding) | = 0.344 uM | DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol) | ChEMBL. | No reference |
Ki (binding) | = 0.452 uM | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | ChEMBL. | No reference |
Ki (binding) | = 0.969 uM | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | ChEMBL. | No reference |
LD50 (ADMET) | 0 mg kg-1 | Compound was tested for its toxicity after oral administration to mice in experiment 1; No data | ChEMBL. | No reference |
LD50 (ADMET) | 0 mg kg-1 | Compound was tested for its toxicity after oral administration to mice in experiment 2; No data | ChEMBL. | No reference |
LD50 (ADMET) | = 15.9 mg kg-1 | Compound was tested for its toxicity after intravenous administration to mice in experiment 2 | ChEMBL. | No reference |
LD50 (ADMET) | = 17 mg kg-1 | Compound was tested for its toxicity after intravenous administration to mice in experiment 1 | ChEMBL. | No reference |
Potency (functional) | 9.5283 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 18.1056 uM | PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 21.1923 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Potency (binding) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.